BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16529147)

  • 1. Management of Hodgkin lymphoma.
    Ansell SM; Armitage JO
    Mayo Clin Proc; 2006 Mar; 81(3):419-26. PubMed ID: 16529147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin lymphoma: 2014 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2014 Jul; 89(7):771-9. PubMed ID: 24953862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2012 Dec; 87(12):1096-103. PubMed ID: 23151980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the initial management of Hodgkin's Lymphoma.
    Marri PR; Ansell SM
    Transfus Apher Sci; 2013 Aug; 49(1):12-8. PubMed ID: 23769695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2016 Jun; 91(4):434-42. PubMed ID: 27001163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual clinical updates in hematological malignancies: a continuing medical education series. Hodgkin lymphoma: 2011 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2011 Oct; 86(10):851-8. PubMed ID: 21922525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin Lymphoma: Diagnosis and Treatment.
    Ansell SM
    Mayo Clin Proc; 2015 Nov; 90(11):1574-83. PubMed ID: 26541251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin lymphoma.
    Gobbi PG; Ferreri AJ; Ponzoni M; Levis A
    Crit Rev Oncol Hematol; 2013 Feb; 85(2):216-37. PubMed ID: 22867814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2018 May; 93(5):704-715. PubMed ID: 29634090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.
    Rueda Domínguez A; Alfaro Lizaso J; de la Cruz Merino L; Gumá I Padró J; Quero Blanco C; Gómez Codina J; Llanos Muñoz M; Martinez Banaclocha N; Rodriguez Abreu D; Provencio Pulla M
    Clin Transl Oncol; 2015 Dec; 17(12):1005-13. PubMed ID: 26497354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin lymphoma: A 2020 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2020 Aug; 95(8):978-989. PubMed ID: 32384177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2022 Nov; 97(11):1478-1488. PubMed ID: 36215668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage therapy for Hodgkin's lymphoma.
    Quddus F; Armitage JO
    Cancer J; 2009; 15(2):161-3. PubMed ID: 19390313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and staging of Hodgkin lymphoma].
    Ghesquières H
    Rev Prat; 2023 Jun; 73(6):617-620. PubMed ID: 37458549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular lymphocyte predominant Hodgkin lymphoma.
    Lee AI; LaCasce AS
    Oncologist; 2009 Jul; 14(7):739-51. PubMed ID: 19605845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing relapsed and refractory Hodgkin lymphoma.
    Brice P
    Br J Haematol; 2008 Apr; 141(1):3-13. PubMed ID: 18279457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin lymphoma in Tyrol-a population-based study.
    Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
    Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal treatment for relapsing patients with Hodgkin lymphoma.
    Sibon D; Brice P
    Expert Rev Hematol; 2009 Jun; 2(3):285-95. PubMed ID: 21082970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful administration of rituximab-bendamustine regimen in the relapse of Hodgkin lymphoma after autologous hemopoietic stem cell transplantation.
    Magyari F; Simon Z; Barna S; Udvardy M; Váróczy L; Illés Á
    Hematol Oncol; 2012 Jun; 30(2):98-100. PubMed ID: 22034208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.